$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Lenvaxen治疗甲状腺癌效果怎么样?
2025-10-19 11:44:20
Check Details
Sorafenat对甲状腺癌有多大效果?
2025-10-19 11:44:20
Check Details
多吉美治疗甲状腺癌患者的疗效如何呢?
2025-10-19 11:44:20
Check Details
卡博替尼对甲状腺癌能有多大疗效?
2025-10-19 11:44:20
Check Details
XL184治疗甲状腺癌疗效怎么样呢?
2025-10-19 11:44:20
Check Details
Cabozantinib治疗甲状腺癌效果怎样呢?
2025-10-19 11:44:20
Check Details
基因检测在甲状腺癌患者的测序治疗中变得至关重要!
2025-10-19 11:44:20
Check Details
拉罗替尼治疗甲状腺癌患者效果如何?
2025-10-19 11:44:20
Check Details
LOXO101治疗甲状腺癌效果如何呢?
2025-10-19 11:44:20
Check Details
新药普雷西替尼获FDA批准,治疗RET+髓样甲状腺癌
2025-10-19 11:44:20
Check Details
疾病控制率可达100%,Pralsetinib令人惊喜!
2025-10-19 11:44:20
Check Details
多吉美治疗甲状腺癌患者疗效怎么样呢?
2025-10-19 11:44:20
Check Details
1
2
...
2496
2497
2498
2499
2500
2501
2502
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
2
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
3
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
4
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
5
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
6
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
7
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
8
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
9
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
10
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
11
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity
12
Tivozanib Dosing Guide for Renal Cell Carcinoma: 21-Day On/7-Day Off Cycle and Adjustments